The full expression of locomotor and motor hyperactivities induced by pressure requires both striatal dopaminergic and N-methyl-D-aspartate receptor activities in the rat

Neuroscience Letters

Volumn 267, Issue 3, 1999, Pages 149-152

  Darbin, O ^a   Risso, J J ^b   Rostain, J C ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b Military Teaching Hospital Sainte Anne   (France)

Author keywords

Aminoacids; Dopamine; High pressure neurological syndrome; Myoclonia; N Methyl D aspartate; Tremor

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMIC ACID; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; GENE EXPRESSION; HIGH PRESSURE NEUROLOGICAL SYNDROME; HYPERACTIVITY; HYPERBARISM; INTRACEREBRAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MICRODIALYSIS; MYOCLONUS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; TREMOR;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2-AMINO-5-PHOSPHONOVALERATE; ANIMALS; CORPUS STRIATUM; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HIGH PRESSURE NEUROLOGICAL SYNDROME; HYPERKINESIS; MALE; MICRODIALYSIS; MYOCLONUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, N-METHYL-D-ASPARTATE; SULPIRIDE; TREMOR;

EID: 0033522855     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00147-0     Document Type: Article

References (21)

1. Abraini J.H., Rostain J.C. Pressure-induced striatal dopamine release correlates hyperlocomotor activity in rats exposed to high pressure. J. Appl. Physiol. 71:1991;638-643.
2. Abraini J.H., Tomei C., Rostain J.C. Role of dopamine receptors in the occurrence of behavioural motor disturbances in rats exposed to high pressure. Pharmacol. Biochem. Behav. 39:1991;773-779.
3. Bennett P.B., Rostain J.C. The high pressure nervous syndrome. Bennett P.B., Elliott D.H. The Physiology and Medicine of Diving. 1993;194 Saunders, London.
4. Darbin, O., Risso, J.J. and Rostain J.C., High Pressure of Helium-Oxygen induces Striatal Glutamatergic Hyperactivity: a Microdialysis and Behavioral Study. 23rd Annual Meeting of the European Underwater and Baromedical Society, Slovenia, 1997.
5. Darbin O., Risso J.J., Rostain J.C. Pressure induces striatal serotonin and dopamine increase: a simultaneous analysis in free-moving microdialyzed rats. Neurosci. Lett. 238:1997;69-72.
6. Darbin O., Risso J.J., Rostain J.C. A new system analysis of motor and locomotor activities associated with a microdialysis study of pressure-induced dopamine increase in rats. Physiol. Behav. 62:1997;367-371.
7. Fechtali T., Abraini J.H., Kriem B., Rostain J.C. Pressure increases de novo synthesized striatal dopamine release in free-moving rats. NeuroReport. 5:1994;725-728.
8. Forni C., Rostain J.C. Effect of helium-oxygen pressure on dopamine detected in vivo in the striatum of hamsters. J. Appl. Physiol. 67:1989;1617-1622.
9. Glantz S.A. Primer of Biostatistics. 1981;McGraw-Hill, New York.
10. Hu X.T., White F.J. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors. Neurosci. Lett. 224:1997;61-65.
11. König J.F.R., Klippel R.A. The Rat Brain: A Stereotaxic Atlas. 1967;R.E. Kriegger, New York.
12. Meldrum B., Wardley-Smith B., Halsey M., Rostain J.C. 2-Amino-phosphoheptanoic acid protects against the high pressure neurological syndrome. Eur. J. Pharmacol. 87:1983;501-502.
13. Millan M.H., Wardley-Smith B., Halsey M.J., Meldrum B.S. Brain nuclei and neurotransmitters involved in the regulation of the high pressure neurological syndrome in the rat. Neuropharmacology. 30:1991;1351-1355.
14. Millan M.H., Wardley-Smith B., Halsey M.J., Meldrum B.S. Studies on the role of NMDA receptor in the substancia nigra pars reticulata and entopeduncular nucleus in the development of the high pressure neurological syndrome in rats. Exp. Brain Res. 78:1989;174-178.
15. Morari M., O'Connor W.T., Ungerstedt U., Fuxe K. Dopamine D1 and D2 receptor antagonism differentially modulates stimulations of striatal neurotransmitter levels by N-methyl-D-aspartic acid. Eur. J. Pharmacol. 256:1994;23-30.
16. Nieoullon A., Kerkerian L., Dusticier N. Inhibitory effects of dopamine on high affinity glutamate uptake from rat striatum. Life. Sci. 30:1982;1165-1172.
17. Requin M., Risso J.J. Effects of high pressure on striatal dopamine release in freely moving rats: a microdialysis study. Neurosci. Lett. 146:1992;211-214.
18. Rostain J.C. The high pressure nervous syndrome at the central nervous system level. Jannnasch H.W., Marquis R.E., Zimmerman A.M. Current Perspective in High Pressure Biology. 1987;137 Academic Press, London.
19. Rostain J.C. The nervous system: man and laboratory mammals. Macdonald A.G. Advance in Comparative and Environmental Physiology: Effects of High Pressure on Biological Systems. 1993;198 Springer-Verlag, Berlin.
20. Siegel S., Castellan N.J. Non-Parametric Statistics for the Behavioral Science. 1989;McGraw-Hill, New York.
21. Wardley-Smith B., Meldrum B.S. Effect of excitatory amino acid antagonists on the high pressure neurological syndrome in rats. Eur. J. Pharmacol. 105:1984;351-354.